The Diagnostic Value of sTWEAK in Acute Ischemic Stroke


Comertpay E., VURAL S. , EROĞLU O., BADEM N. D. , Bilgili Y. K. , Coskun F.

BALKAN MEDICAL JOURNAL, vol.37, no.6, pp.336-340, 2020 (Journal Indexed in SCI) identifier identifier identifier

Abstract

Background: Considering the critical role of early diagnosis and management of acute ischemic stroke, biomarkers that can reliable assist in the diagnosis are still needed. These biomarkers should rapidly analyze, have high specificity for brain damage, and be available in the emergency settings for early diagnosis and exclusion of other conditions that mimic acute ischemic stroke. Soluble tumor necrosis factor-like weak inducer of apoptosis, a protein involved in the regulation of several biological functions, could be a potential acute ischemic stroke biomarker.